Questions people ask about Abnehmspritze Kinder

The safety of weight loss injections like Ozempic/Wegovy (semaglutide) for children is a serious medical question. MyBody-X does not provide specific guidance on this. These GLP-1 receptor agonists are approved in the EU and USA for adolescents aged 12+ with obesity, but only under medical supervision. Side effects include gastrointestinal issues, and long-term risks (pancreatitis, thyroid tumors) are monitored. Clinical trials (e.g., STEP-TEENS) show efficacy but require lifestyle support. MyBody-X DNA tests are not intended for minors (German GenDG) and cannot replace a doctor's advice. Parents should seek pediatric endocrinology consultation. Evidence: human-strong (clinical guidelines). Sources: none directly from provided context.